This second edition provides an updated review on the current guidelines and practice standards for the clinical management of cardiovascular risk factors and prevention of cardiovascular diseases. Endorsed by the American Society for Preventive Cardiology, this practical textbook includes concise descriptions of major and newer risk factors, biomarkers, and best practices in the management and prevention of cardiovascular disease. The manual contains chapters on the epidemiology and risk factors for a variety of cardiovascular diseases including dyslipidemia, hypertension, diabetes, inflammation, and ischemic stroke. It examines behavioral factors, psychosocial stress, family history, nutrition, physical activity, smoking, alcohol use, and other sociocultural factors. In addition, the book discusses new imaging strategies in detection of cardiovascular disease, prevention of heart failure, atrial fibrillation, and peripheral arterial disease, and prevention for special populations. Throughout the manual, recommendations are based on guidelines endorsed by the American College of Cardiology, American Heart Association, and other major societies.
The second edition of the ASPC Manual of Preventive Cardiology is an essential resource for physicians, medical students, residents, fellows, nurses, and other healthcare professionals and researchers in cardiology, primary care, health promotion and disease prevention, exercise physiology, and pharmacotherapy.

Focuses on communication and implementation of latest guidelines for cardiovascular disease prevention Examines psychosocial stress, family history, nutrition, physical activity, smoking, and alcohol use Covers all major and important emerging cardiovascular risk factors, key methodologies in risk assessment, and special issues regarding specific patient populations Discusses prevention of coronary heart disease, heart failure, peripheral arterial disease, atrial fibrillation, ischemic stroke, and other cardiovascular diseases

Autorentext
Nathan D. Wong, PhD, FACC, FAHA, FASPC, FNLA

Professor and Director, Heart Disease Prevention Program

Division of Cardiology, University of California, Irvine

Adjunct Professor of Epidemiology (UCLA and UC Irvine) and Population Sciences (UC Irvine)

Past President, American Society for Preventive Cardiology

C240 Medical Sciences

Irvine, CA 92697-4079, USA

T: 949-824-5561

Email: ndwong@uci.edu

Ezra A. Amsterdam, MD, FACC, FAHA

Distinguished Professor of Medicine

Associate Chief, Division of Cardiovascular Medicine

Past President, American Society for Preventive Cardiology

Department of Internal Medicine

University of California (Davis) Medical Center

4086 Y Street

Sacramento, CA 95817, USA

T: 916-734-5191

Email: eaamsterdam@ucdmc.edu

Peter P. Toth, MD, PhD, FAAFP, FCCP, FNLA, FASPC, FESC, FACC

Professor of Clinical Family and Community Medicine

University of Illinois School of Medicine

Adjunct Associate Professor of Medicine

Ciccarone Center for Cardiovascular Disease Prevention, Johns Hopkins University President, American Society for Preventive Cardiology 101 East Miller Road

Sterling, IL 61081, USA

Email: Peter.Toth@cghmc.com

Inhalt

Chapter. 1: Focus on Cardiovascular Health Promotion and Disease Prevention- Opportunities for Improvement.- Chapter. 2: National and Global Trends of Cardiovascular Disease Mortality, Morbidity, and Risk.- Chapter. 3: Cardiovascular Risk Assessment: From Global Risk Scoring to Risk Enhancing Factors.- Chapter. 4: Assessment and Management of Psychosocial Risk Factors within Preventive Cardiology Practice.- Chapter. 5: Dietary Strategies for Atherosclerotic Cardiovascular Risk Reduction.- Chapter. 6: Physical Activity Strategies.- Chapter. 7: Obesity Management and Prevention of Cardiovascular Disease.- Chapter. 8: Smoking and Vaping.- Chapter. 9: Alcohol and Cardiovascular Diseases.- Chapter. 10: The 2018 AHA/ACC/Multi-Society Cholesterol guidelines: A personalized approach to risk reduction.- Chapter. 11: Blood Pressure and Hypertension Management.- Chapter. 12: Cardiodiabetology: Reducing Risks to Optimize Cardiovascular Disease Outcomes.- Chapter. 13: Antiplatelet Therapy.- Chapter. 14: Inflammation and Atherosclerotic Cardiovascular Disease.- Chapter. 15: The Role of Genetics in Preventive Cardiology: Utility of Clinically Available Genetic Tests.- Chapter. 16: Exercise Electrocardiographic Stress Testing.- Chapter. 17: Ultrasound and MRI Assessment of Cardiovascular Risk.- Chapter. 18: Role of CT Coronary Calcium Scanning and Angiography in Evaluation of Cardiovascular Risk.- Chapter. 19: Cardiovascular Disease Prevention in Women.- Chapter. 20: Racial/Ethnic Considerations in the Prevention of Cardiovascular Disease.- Chapter. 21: Prevention of Heart Failure.- Chapter. 22: Prevention of Peripheral Arterial Disease.- Chapter. 23: Prevention of Atrial Fibrillation.- Chapter. 24: Prevention of Ischemic Stroke.- Chapter. 25: Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease.- Chapter. 26: Primary Prevention of Cardiovascular Disease Guidelines.- Chapter. 27: Secondary Prevention and Cardiac Rehabilitation.- Chapter. 28: Integrative Approaches for Cardiovascular Disease Prevention.- Chapter. 29: Preventive Cardiology as Specialized Medical Art.